- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Board Meeting, 05-02-2026: Outcome of Board Meeting
05-02-2026 | 02:00 pm
05-02-2026 | 02:00 pm
Alembic Pharma's Board approved Q3 FY26 consolidated results, with revenue at ₹1,876.31 Cr and profit at ₹132.97 Cr. Mr. Rajkumar Baheti was also appointed as Non-Executive Director, effective April 1, 2026.
No comments yet. Be the first to comment!